With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Developmental Therapeutics and Translational Research Program||Children’s Hospital of Philadelphia / John Maris||Phase I/II Infrastructure Grants||2005||Pennsylvania|
|Pediatric Oncology Translational Research Program.||Vanderbilt University Medical Center / James Whitlock, MD||Phase I/II Infrastructure Grants||2006||Tennessee|
|WIP1 Modulates Responsiveness of MB to Genotoxic Stress.||Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Robert Craig Castellino, MD||Young Investigator Grants||2006||Georgia|
|MTG-16 Regulation by Phosphorylation||Vanderbilt University Medical Center / Michael Engel, MD, PhD||Young Investigator Grants||2006||Tennessee|
|Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma||Children’s Hospital of Philadelphia / Naomi Balamuth, MD||Young Investigator Grants||2006||Pennsylvania|
|Research Institute at Nationwide Children's Hospital / Mary Beth Ross, MD/PhD||Young Investigator Grants||2006||Ohio|
|Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma||The Pennsylvania State University / Ken Lucas, MD||Innovation Grants||2006||Pennsylvania|
|Parallel sequencing to identify the causes of childhood cancer.||Baylor College of Medicine / Sharon Plon, MD, PhD||Innovation Grants||2006||Texas|
|Anti-Angiogenic (Metronomic) Chemotherapy in Children with Poor Prognosis.||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD||Innovation Grants||2006||Massachusetts|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|